Category: Vaccination
CDC announces massive overhaul of child vax schedule, drops numerous recommended jabs
At the time President Donald Trump took office last year, the Centers for Disease Control and Prevention was recommending that all American children get vaccines for 18 diseases, loading kids up with more than twice as many doses as their European counterparts were receiving.
As the result of an overhaul of the schedule announced on Monday, the agency is now recommending universal childhood vaccinations for only 11 diseases.
‘America will no longer require 72 “jabs” for our beautiful, healthy children.’
Trump issued a presidential memorandum last month directing Health and Human Services Secretary Robert F. Kennedy Jr. and Jim O’Neill, the acting CDC director, to “review best practices from peer, developed countries for core childhood vaccination recommendations — vaccines recommended for all children — and the scientific evidence that informs those best practices.”
In the event that they found that foreign practices were superior to current domestic recommendations, Trump tasked Kennedy and O’Neill with updating the U.S. childhood vaccine schedule accordingly.
O’Neill discussed childhood vaccine recommendations and policy with health officials from various first-world nations as well as with vaccine safety experts at the CDC and the U.S. Food and Drug Administration.
RELATED: How Big Pharma left its mark on woke CDC vax advisory panel — and what RFK Jr. did about it
Photo by Andrew Harnik/Getty Images
He also reviewed a comprehensive scientific assessment that not only compared American vaccine recommendations with dozens of other first-world nations but “analyzed vaccine uptake and public trust, evaluated clinical and epidemiological evidence and knowledge gaps, examined vaccine mandates, and identified next steps.”
The CDC indicated that the assessment “found that the U.S. is a global outlier among developed nations in both the number of diseases addressed in its routine childhood vaccination schedule and the total number of recommended doses but does not have higher vaccination rates than such countries.”
O’Neill ultimately approved a corresponding decision memo from the agency heads of the National Institutes of Health, the FDA, and the Centers for Medicaid and Medicare, recommending immunization for measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilius influenzae type B, pneumococcal disease, human papillomavirus, and chickenpox for all children.
While the core schedule now recommends only these 11 — just one more than is recommended in Denmark — the CDC recommends on an individual basis: RSV, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWAY, and dengue vaccines for “high-risk groups” and hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, and COVID-19 vaccines.
The overhaul has evidently vexed elements of the medical establishment who oversaw the precipitous decline in trust in U.S. public health.
‘This decision protects children.’
“Today’s announcement that HHS is drastically altering the U.S. childhood vaccine schedule without a transparent process or clear scientific justification represents the latest reckless step in Secretary Kennedy’s assault on the national vaccine infrastructure that has saved millions of lives. His actions put families and communities at risk and will make America sicker,” Ronald Nahass, the president of the Infectious Diseases Society of America, said in a statement.
Ofer Levy, director of the Precision Vaccines Program at Boston Children’s Hospital, likewise questioned the transparency of the process, suggesting “not all of this was really hashed out in a discussion that was available for the public to listen to and participate in.”
O’Neill noted that these changes are part of a broader effort to regain the trust of the American people.
“One of the consequences was parents declining recommended vaccines for their children,” stated O’Neill. “Parents who think that more than 80 doses per child is too many may now consider giving their children the 10 vaccines in the international consensus of 20 nations, plus the varicella vaccine.”
Kennedy thanked O’Neill for his “leadership and bravery” and noted that “this decision protects children, respects families, and rebuilds trust in public health.”
“This Schedule is rooted in the Gold Standard of Science, and widely agreed upon by Scientists and Experts all over the World,” Trump stated on Truth Social.
“Effective today, America will no longer require 72 ‘jabs’ for our beautiful, healthy children,” continued the president. “We are moving to a far more reasonable Schedule, where all children will only be recommended to receive Vaccinations for 11 of the most serious and dangerous diseases.”
Trump and federal health officials emphasized both that parents can continue to give their children the vaccinations dropped from the schedule and that insurance will continue to cover them.
Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!
Pfizer COVID shot sales plummet after Trump administration ends universal recommendations
U.S. sales of Pfizer’s Comirnaty shots have taken a nosedive since the Trump administration updated its immunization schedules last month and dropped the universal collective recommendations for COVID-19 vaccines.
The pharmaceutical company’s revenues for the third quarter of 2025 are down 6% — amounting to a $1 billion drop — compared to the same stretch the previous year.
‘CDC’s 2022 blanket recommendation for perpetual COVID-19 boosters deterred health care providers from talking about the risks.’
Pfizer indicated in its latest earnings statement that “the operational decrease was primarily driven by a year-over-year decline in COVID-19 product revenues largely due to lower infection rates impacting Paxlovid demand as well as a narrower vaccine recommendation for COVID-19 in the U.S. that reduced the eligible population for Comirnaty.”
Sales of Comirnaty were down 25% in the United States, and sales of Paxlovid, an oral antiviral medication that treats mild-to-moderate COVID-19 in adults, were down 52%.
When his agency dropped the universal recommendation last month for Comirnaty — a controversial vaccine used at a time of population-wide immunity to treat an endemic virus fatal in roughly 1% of confirmed cases — Centers for Disease Control and Prevention Acting Director Jim O’Neill stated, “CDC’s 2022 blanket recommendation for perpetual COVID-19 boosters deterred health care providers from talking about the risks and benefits of vaccination for the individual patient or parent. That changes today.”
RELATED: Naomi Wolf continues to expose COVID vaccine: ‘A depopulating technology’
Photo by PATRICK T. FALLON/AFP via Getty Images
The CDC’s decision came just months after the U.S. Food and Drug Administration forced Pfizer to slap a damning warning on its Comirnaty vaccine noting the estimated unadjusted incidence of heart conditions following administration of the 2023-2024 formula of the shot, as well as the longitudinal results of a 2024 study concerning cardiac manifestations and outcomes of vaccine-associated myocarditis in American youths.
The FDA also required Pfizer to describe the new safety information in the adverse reactions section of its vaccine information insert such that it now notes that “the estimated unadjusted incidence of myocarditis and/or pericarditis during the period 1 through 7 days following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines was approximately 8 cases per million doses in individuals 6 months through 64 years of age and approximately 27 cases per million doses in males 12 through 24 years of age.”
While the FDA has approved the drug for use in individuals who are 65 years of age and older or 5-64 years old who suffer from at least one underlying condition putting them at high risk for severe outcomes from COVID-19, it revoked the emergency use authorization for the shot in August.
Pfizer CEO Albert Bourla reportedly suggested on a Tuesday call with analysts that the company is looking for opportunities outside the United States, stating that the company’s catalog of vaccines constitute a “key area of focus in international markets.”
Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!
